AUROPHARMAAurobindo Pharma Ltd.

    Aurobindo Pharma Ltd: results and news

    Every Aurobindo Pharma Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: earnings, mergers & acquisitions.

    2 articles · Pharmaceuticals · Latest 4 Nov 2026

    A dark wooden apothecary cabinet with small drawers and shelves holding white and blue glass medicine bottles, in a museum display.

    AUROPHARMAAurobindo Pharma Ltd.

    Aurobindo Pharma Q2 FY27 Results: Consolidated Net Profit ₹1,124 Crore on Total Income of ₹10,432 Crore

    Aurobindo Pharma (NSE: AUROPHARMA) reported consolidated total income of ₹10,431.51 crore and net profit of ₹1,123.84 crore for the quarter ended 30 Sep 2026, it said in a filing on 04 Nov 2026. Standalone total income was ₹3,280.13 crore and standalone net profit ₹723.58 crore for the same quarter.

    • Earnings
    • pharmaceuticals

    Blacklitt Research3 min read